These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 39003309

  • 21. Decreased Serum C3 Levels in Immunoglobulin A (IgA) Nephropathy with Chronic Kidney Disease: A Propensity Score Matching Study.
    Yang X, Wei RB, Wang Y, Su TY, Li QP, Yang T, Huang MJ, Li KY, Chen XM.
    Med Sci Monit; 2017 Feb 06; 23():673-681. PubMed ID: 28166191
    [Abstract] [Full Text] [Related]

  • 22. Relationship between complement deposition and the Oxford classification score and their combined effects on renal outcome in immunoglobulin A nephropathy.
    Park S, Kim HW, Park JT, Chang TI, Kang EW, Ryu DR, Yoo TH, Chin HJ, Jeong HJ, Kang SW, Lim BJ, Han SH.
    Nephrol Dial Transplant; 2020 Dec 04; 35(12):2103-2137. PubMed ID: 31377783
    [Abstract] [Full Text] [Related]

  • 23. C3, C4, factor B and HLA-DR alpha mRNA expression in renal biopsy specimens from patients with IgA nephropathy.
    Oren R, Laufer J, Goldberg I, Kopolovic J, Waldherr R, Passwell JH.
    Immunology; 1995 Dec 04; 86(4):575-83. PubMed ID: 8567024
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Association of time-averaged serum uric acid level with clinicopathological information and long-term outcomes in patients with IgA nephropathy.
    Weng M, Fu B, Zhuo Y, Lin J, Zou Z, Chen Y, Cui J, Li G, Chen C, Xu Y, Jiang D, Wan J.
    PeerJ; 2024 Dec 04; 12():e17266. PubMed ID: 38650643
    [Abstract] [Full Text] [Related]

  • 26. Is There a Role for IgA/C3 Ratio in IgA Nephropathy Prognosis? An Outcome Analysis on An European Population.
    Stefan G, Stancu S, Boitan B, Zugravu A, Petre N, Mircescu G.
    Iran J Kidney Dis; 2020 Dec 04; 14(6):470-477. PubMed ID: 33277451
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Circulating complement factor H-related proteins 1 and 5 correlate with disease activity in IgA nephropathy.
    Medjeral-Thomas NR, Lomax-Browne HJ, Beckwith H, Willicombe M, McLean AG, Brookes P, Pusey CD, Falchi M, Cook HT, Pickering MC.
    Kidney Int; 2017 Oct 04; 92(4):942-952. PubMed ID: 28673452
    [Abstract] [Full Text] [Related]

  • 29. Serum IgA/C3 ratio may predict diagnosis and prognostic grading in patients with IgA nephropathy.
    Ishiguro C, Yaguchi Y, Funabiki K, Horikoshi S, Shirato I, Tomino Y.
    Nephron; 2002 Aug 04; 91(4):755-8. PubMed ID: 12138285
    [Abstract] [Full Text] [Related]

  • 30. Activated complement C3: a potentially novel predictor of progressive IgA nephropathy.
    Zwirner J, Burg M, Schulze M, Brunkhorst R, Götze O, Koch KM, Floege J.
    Kidney Int; 1997 Apr 04; 51(4):1257-64. PubMed ID: 9083294
    [Abstract] [Full Text] [Related]

  • 31. Serum complement factor B is associated with disease activity and progression of idiopathic membranous nephropathy concomitant with IgA nephropathy.
    Ji FP, Wen L, Zhang YP, Liu EP, Wen JG.
    Int Urol Nephrol; 2022 Jun 04; 54(6):1287-1294. PubMed ID: 34585312
    [Abstract] [Full Text] [Related]

  • 32. Decreased circulating C3 levels and mesangial C3 deposition predict renal outcome in patients with IgA nephropathy.
    Kim SJ, Koo HM, Lim BJ, Oh HJ, Yoo DE, Shin DH, Lee MJ, Doh FM, Park JT, Yoo TH, Kang SW, Choi KH, Jeong HJ, Han SH.
    PLoS One; 2012 Jun 04; 7(7):e40495. PubMed ID: 22792353
    [Abstract] [Full Text] [Related]

  • 33. Urinary Matrix Metalloproteinase 7 and Prediction of IgA Nephropathy Progression.
    Yang X, Ou J, Zhang H, Xu X, Zhu L, Li Q, Li J, Xie D, Sun J, Zha Y, Li Y, Tian J, Liu Y, Hou FF.
    Am J Kidney Dis; 2020 Mar 04; 75(3):384-393. PubMed ID: 31606236
    [Abstract] [Full Text] [Related]

  • 34. Clinical and prognostic significance of C1q deposition in IgAN patients-a retrospective study.
    Tian S, Yang X, Luo J, Guo H.
    Int Immunopharmacol; 2020 Nov 04; 88():106896. PubMed ID: 33182045
    [Abstract] [Full Text] [Related]

  • 35. Elevated factor H-related protein 1 and factor H pathogenic variants decrease complement regulation in IgA nephropathy.
    Tortajada A, Gutiérrez E, Goicoechea de Jorge E, Anter J, Segarra A, Espinosa M, Blasco M, Roman E, Marco H, Quintana LF, Gutiérrez J, Pinto S, Lopez-Trascasa M, Praga M, Rodriguez de Córdoba S.
    Kidney Int; 2017 Oct 04; 92(4):953-963. PubMed ID: 28637589
    [Abstract] [Full Text] [Related]

  • 36. Circulating complement factor H-related protein 5 levels contribute to development and progression of IgA nephropathy.
    Zhu L, Guo WY, Shi SF, Liu LJ, Lv JC, Medjeral-Thomas NR, Lomax-Browne HJ, Pickering MC, Zhang H.
    Kidney Int; 2018 Jul 04; 94(1):150-158. PubMed ID: 29759419
    [Abstract] [Full Text] [Related]

  • 37. Comparison of laboratory findings in patients with glomerulonephritis classified according to histopathologic diagnosis.
    Kirac Y, Bilen S, Duranay M.
    Minerva Med; 2014 Apr 04; 105(2):149-56. PubMed ID: 24727879
    [Abstract] [Full Text] [Related]

  • 38. Glomerular deposition and serum levels of complement control proteins in patients with IgA nephropathy.
    Miyazaki R, Kuroda M, Akiyama T, Otani I, Tofuku Y, Takeda R.
    Clin Nephrol; 1984 Jun 04; 21(6):335-40. PubMed ID: 6205804
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Activation of the alternative complement pathway predicts renal outcome in patients with lupus nephritis.
    Kim H, Kim T, Kim M, Lee HY, Kim Y, Kang MS, Kim J.
    Lupus; 2020 Jul 04; 29(8):862-871. PubMed ID: 32408850
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.